Roivant Sciences Balance Sheet
ROIV / Health Care|6 years of annual SEC 10-K data (FY2020-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | - | $6.5B | $1.7B | $2.1B | $2.1B | - |
| Inventory | - | $35.3M | $2.8M | - | - | - |
| Current Assets | - | $6.7B | $1.8B | $2.1B | $2.2B | - |
| PP&E (Net) | - | $15.3M | $39.1M | $25.9M | $14.7M | - |
| Total Assets | - | $7.2B | $2.4B | $2.6B | $2.6B | - |
| Current Liabilities | - | $266.8M | $272.4M | $184.4M | $219.0M | - |
| Total Debt | - | $430.6M | $375.5M | $210.0M | $170.3M | - |
| Shareholders' Equity | - | $6.0B | $1.2B | $1.7B | $2.0B | $2.1B |